Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer.

MLA

Omori, Miwako, et al. “Inhibitors of ABCB1 and ABCG2 Overcame Resistance to Topoisomerase Inhibitors in Small Cell Lung Cancer.” Thoracic Cancer, vol. 13, no. 15, Aug. 2022, pp. 2142–51. EBSCOhost, https://doi.org/10.1111/1759-7714.14527.

APA

Omori, M., Noro, R., Seike, M., Matsuda, K., Hirao, M., Fukuizumi, A., Takano, N., Miyanaga, A., & Gemma, A. (2022). Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer. Thoracic Cancer, 13(15), 2142–2151. https://doi.org/10.1111/1759-7714.14527

Chicago

Omori, Miwako, Rintaro Noro, Masahiro Seike, Kuniko Matsuda, Mariko Hirao, Aya Fukuizumi, Natsuki Takano, Akihiko Miyanaga, and Akihiko Gemma. 2022. “Inhibitors of ABCB1 and ABCG2 Overcame Resistance to Topoisomerase Inhibitors in Small Cell Lung Cancer.” Thoracic Cancer 13 (15): 2142–51. doi:10.1111/1759-7714.14527.